Search filters

Filters
Clear All

Phase

  • 67
  • 71
  • 1
  • 86
  • 1
  • 60
  • 13
  • 201
  • 576
  • 219
  • 9
  • 25
  • 545
  • 575
  • 4
  • 1
  • 578

Found 579 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Digital Data and Heart Health | Using Digital Data to Predict Heart Disease
30 years - 74 years
All genders
Observational
What is the purpose of this study?   This research study is exploring about how digital data (ie. social media, online searches, and step tracking data) are associated with Coronary Heart Disease (CHD) and related risk factors in order to develop a more precise CHD risk predictor tool.   We …
18 years - 69 years
All genders
Phase 2
Are you still experiencing celiac disease symptoms despite your best efforts to follow a gluten-free diet?The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015. In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused …
12 years - 30 years
All genders
We are seeking young people who are concerned about recent changes in mood, thinking or behavior.  This research project aims to increase understanding of mental health concerns in young people and how to prevent the development of a more serious mental illness such as psychosis.
 Impact of Nicotine Messaging on Beliefs and Behavior
21 years - 100 years
All genders
The purpose of this study is to examine the impact of nicotine messaging on beliefs and behavior while using investigational cigarettes with either normal nicotine levels or reduced nicotine levels.
 Towards Objective Metrics to Quantify the Role of HIV and Increasing Cognitive Demand on Instrumental ADLs in People Aging with HIV
50 years - 100 years
All genders
The objective of this proposal is to examine the utility of a robot-based approach to study instrumental activities of daily living (IADLs) function and cognitive-motor performance in persons aging with HIV. IADLs often require high levels of executive functioning during the performance of motor activities, but there are no good …
 General Screening Protocol for Affected and Unaffected Participants in Studies of Substance Use Disorders
18 years - 64 years
All genders
The goal of this study is to evaluate individuals with and without substance use disorder (SUD) to determine whether it is safe and appropriate for them to participate in a clinical trial, imaging study, or other research protocol that matches the participants’ interests and eligibility. Our goal is to enroll …
99 years or below
All genders
To compare the effectiveness of two approaches for the management of BE and LGD, endoscopic surveillance and endoscopic eradication therapy (EET), using accepted clinical endpoints of neoplastic progression [high-grade dysplasia (HGD)/mucosal esophageal adenocarcinoma (EAC)/invasive EAC] as determined by a blinded central adjudication committee
99 years or below
All genders
Phase 4
PURPOSE/DESCRIPTION: The purpose of this study is to determine the most efficacious and safest dexamethasone dose given intraoperatively during total knee arthroplasty that reduces postoperative opioid consumption and pain, improves postoperative nausea and vomiting, and minimizes postoperative complications.
99 years or below
All genders
Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus that can lead to remodeling and stricture formation. To assess response to therapy, upper endoscopy (EGD) with biopsies is performed. This can lead to multiple EGDs, which are invasive and costly. There is currently a substantial unmet need for …
 Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome (AEGIS-II)
18 years - 99 years
All genders
Phase 3
Interventional
This is a multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events (MACE) in subjects with Acute Coronary Syndrome (diagnosed with STEMI or NSTEMI), who are receiving evidence-based medical therapy.